C-Suite Advisory

3 Traits Every Biotech CEO and Leader Should Have

Christina DiArcangelo

Leading a biotech organization can be described by some as complex, intriguing, transformational, stressful, and impactful. Sounds like a lot to manage, doesn’t it? Those who fill leadership roles in these organizations are tasked with going up against challenges and facing situations that are not fluid across all industries. Biotech can involve clinical trials, drug development, medical equipment, and a plethora of other aspects within the industry.

The common denominator here is that those paving the way in this industry are having a direct impact on how we move modern medicine forward, treat diseases and ailments that have been challenging even for some of the brightest teams, and improve the quality of life for people all over the globe. With this comes leadership that requires unique character traits and skills. Here are three traits every biotech CEO and leader should have.

  1. Empathy
    Have you ever reflected on a situation and only afterwards realized how uncomfortable it was for you at that time? How were you feeling then? Showing empathy for others within the workplace is critical to the health temperature within the organization. If we do not show our hearts to our colleagues in a transparent manner, how will we ever trust one another?

    Empathy aligns with creating an environment of listening and sharing information freely because we feel safe. Empathy, especially in the biotech industry, should be demonstrated as we are working on products to help patients feel better and achieve a greater quality of life.

  2. Patience
    As leaders, we are often enthusiastic about the work that we do. One downfall of having a strong level of passion is that it can potentially lead us to respond or react in ways that might intimidate team members. There may be a situation where your voice gets loud, or you might come across as frustrated or angry due to body language.

    No matter how excited or eager we get as a result of our passion and dedication to the goal at hand, it is critical that we remain patient, take a step back, take a breath, actively listen, and think before we respond. Passion isn’t a bad thing, but it must be balanced with patience and self-awareness so that we embrace the full circle of communication with our team members. My father who was a laborer and a union man used to give teams advice on the art of listening. He would always say, “Do not listen to react. Listen to really listen. Digest what is being said before you say anything.” To this day, this still holds true across all industries, especially biotech.

  3. Ethical-Mindedness
    In the biotech industry, it is imperative that we are always operating at the highest level of ethics and integrity. If subject safety is being impacted, it is a must that we ensure all subjects are safe. Subjects in clinical trials are our priority. Data must be clean and concise. All adverse events and serious adverse events need to be reported. Finding out this information later in the process, after a drug is approved by the FDA, can cause massive criminal and civil issues for a company and potential detriment to subjects and their families.

No matter how big or small your biotech organization is, it is critical to lead with empathy, patience, thoughtfulness, and ethics to ensure that you are doing what is right for your team, your subjects, and the families of which your work is having an impact on.


Written by Christina DiArcangelo.
Have you read?
Best Business Schools In The World For 2022.
Best Fashion Schools In The World For 2022.
Best Hospitality And Hotel Management Schools In The World For 2022.
Best Medical Schools In The World For 2022.
The World’s Best Universities For Doctor of Business Administration (DBA), 2022.

Track Latest News Live on CEOWORLD magazine and get news updates from the United States and around the world. The views expressed are those of the author and are not necessarily those of the CEOWORLD magazine.
Follow CEOWORLD magazine headlines on: Google News, LinkedIn, Twitter, and Facebook.
Thank you for supporting our journalism. Subscribe here.
For media queries, please contact: info@ceoworld.biz
Christina DiArcangelo
An entrepreneur and CEO with more than two decades of experience in the biotechnology, pharmaceutical, nutraceutical, and medical device industries, Christina DiArcangelo’s dedication to revolutionizing patient care is unprecedented. Through her roles as CEO, Spectral Analytics Precision Tele-Monitoring, Affinity Bio Partners, Board President and CEO of Affinity Patient Advocacy, Christina has been involved with revolutionary projects and global clinical studies that positively impact patients.

Christina was a participant and winner in Season 2 of the “Four Days to Save the World” TV Series that will be released on Earth Day 2022. As a clinical research pioneer, contracts negotiator, and business owner, she has utilized the tools at her disposal to champion patient care and provide best-in-class patient advocacy services. For Christina, patient care comes first.


Christina DiArcangelo is an opinion columnist for the CEOWORLD magazine. You can follow her on LinkedIn. For more information, visit the author’s website.